NEURO-CARE Sp. z o.o. Sp. Komandytowa
Siemianowice Slaskie, Poland
Neurologist in Siemianowice Śląskie
Szpitalna 6, 41-100 Siemianowice Śląskie
About NEURO-CARE Sp. z o.o. Sp. Komandytowa
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
ACADIA Pharmaceuticals Inc.
3
Theravance Biopharma
3
Eli Lilly and Company
2
Impax Laboratories, LLC
2
AstraZeneca
1
Biogen
1
Cortexyme Inc.
1
Genentech, Inc.
1
Integrative Research Laboratories AB
1
Clinical Trials at NEURO-CARE Sp. z o.o. Sp. Komandytowa
During the past decade, NEURO-CARE Sp. z o.o. Sp. Komandytowa conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 10 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-09-20
2022-12-30
Completed
835
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
2014-09-30
2018-10-04
Terminated
2,218
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease
2017-10-04
2021-01-15
Terminated
457
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
2017-09-27
2019-10-30
Completed
392
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-08-22
2022-11-28
Terminated
982
A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease
2018-05-21
2022-05-06
Completed
784
Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease
2018-07-17
2023-08-01
Active, not recruiting
597
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "NEURO-CARE Sp. z o.o. Sp. Komandytowa" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "ACADIA Pharmaceuticals Inc." with 3 trials
sponsored, "Theravance Biopharma" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Impax Laboratories, LLC"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NEURO-CARE Sp. z o.o. Sp. Komandytowa"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at NEURO-CARE Sp. z o.o. Sp. Komandytowa
According to Clinical.Site data, the most researched conditions in "NEURO-CARE Sp. z o.o. Sp. Komandytowa" are
"Alzheimer Disease" (5 trials), "Alzheimer's Disease" (3 trials), "Symptomatic Neurogenic Orthostatic Hypotension" (3 trials), "Multiple Sclerosis" (2 trials) and "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials). Many other conditions were trialed in "NEURO-CARE Sp. z o.o. Sp. Komandytowa" in a lesser frequency.
Clinical Trials Intervention Types at NEURO-CARE Sp. z o.o. Sp. Komandytowa
Most popular intervention types in "NEURO-CARE Sp. z o.o. Sp. Komandytowa" are "Drug" (22 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Ocrelizumab" (4 trials), "ampreloxetine" (3 trials), "Donanemab" (2 trials) and "Gantenerumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at NEURO-CARE Sp. z o.o. Sp. Komandytowa
The vast majority of trials in "NEURO-CARE Sp. z o.o. Sp. Komandytowa" are
22 trials for "All" genders.
Clinical Trials Status at NEURO-CARE Sp. z o.o. Sp. Komandytowa
Currently, there are NaN active trials in "NEURO-CARE Sp. z o.o. Sp. Komandytowa".
undefined are not yet recruiting,
4 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in NEURO-CARE Sp. z o.o. Sp. Komandytowa,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in NEURO-CARE Sp. z o.o. Sp. Komandytowa, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of NEURO-CARE Sp. z o.o. Sp. Komandytowa
NEURO-CARE Sp. z o.o. Sp. Komandytowa has several departments that took part in Clinical trials: "Neuro-Care Gabriela Klodowska" - 2 trials
Departments List
Name
City
Trials